Dexcom (DXCM) EBT (2010 - 2026)

Dexcom (DXCM) has 17 years of EBT data on file, last reported at $269.5 million in Q1 2026.

• EBT for Q1 2026 came in at $269.5 million, up 74.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 64.7% YoY), and the FY2025 annual result was $1.1 billion, up 53.51% from the prior year.
• EBT retreated to $269.5 million in Q1 2026 per DXCM's latest filing, from $340.7 million in the prior quarter.
• Over five years, EBT peaked at $352.3 million in Q3 2025 and troughed at $36.1 million in Q1 2022.
• A 5-year average of $186.4 million and a median of $177.4 million in 2024 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2024: EBT surged 1981.25% in 2022, then slipped 26.21% in 2024.
• A 5-year view of EBT shows it stood at $133.2 million in 2022, then soared by 84.83% to $246.2 million in 2023, then decreased by 14.18% to $211.3 million in 2024, then jumped by 61.24% to $340.7 million in 2025, then decreased by 20.9% to $269.5 million in 2026.
• Business Quant data shows DXCM's EBT at $269.5 million in Q1 2026, $340.7 million in Q4 2025, and $352.3 million in Q3 2025.